Next Article in Journal
Restoration of Tear Secretion in a Murine Dry Eye Model by Oral Administration of Palmitoleic Acid
Next Article in Special Issue
Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe
Previous Article in Journal / Special Issue
Dietary Metabolites and Chronic Kidney Disease
Erratum published on 16 June 2017, see Nutrients 2017, 9(6), 614.
Article

Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients

1
Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9700 RB, The Netherlands
2
Division of Human Nutrition, Wageningen University & Research, Droevendaalsesteeg 4, Wageningen 6708 PB, The Netherlands
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2017, 9(4), 363; https://doi.org/10.3390/nu9040363
Received: 28 February 2017 / Revised: 27 March 2017 / Accepted: 30 March 2017 / Published: 5 April 2017
(This article belongs to the Special Issue Nutrition and Chronic Kidney Disease)
The effect of marine-derived omega-3 polyunsaturated fatty acids (n-3 PUFA) on long-term outcome in renal transplant recipients (RTR) remains unclear. We investigated whether marine-derived n-3 PUFA intake is associated with all-cause and cardiovascular (CV) mortality in RTR. Intake of eicosapentaenoic acid plus docosahexaenoic acid (EPA-DHA) was assessed using a validated Food Frequency Questionnaire. Cox regression analyses were performed to evaluate the associations of EPA-DHA intake with all-cause and CV mortality. We included 627 RTR (age 53 ± 13 years). EPA-DHA intake was 102 (42–215) mg/day. During median follow-up of 5.4 years, 130 (21%) RTR died, with 52 (8.3%) due to CV causes. EPA-DHA intake was associated with lower risk of all-cause mortality (Hazard Ratio (HR) 0.85; 95% confidence interval (95% CI) 0.75–0.97). Age (p = 0.03) and smoking status (p = 0.01) significantly modified this association, with lower risk of all-cause and CV mortality particularly in older (HR 0.75, 95% CI 0.61–0.92; HR 0.68, 95% CI 0.48–0.95) and non-smoking RTR (HR 0.80, 95% CI 0.68–0.93; HR 0.74, 95% CI 0.56–0.98). In conclusion, marine-derived n-3 PUFA intake is inversely associated with risk of all-cause and CV mortality in RTR. The strongest associations were present in subgroups of patients, which adds further evidence to the plea for EPA-DHA supplementation, particularly in elderly and non-smoking RTR. View Full-Text
Keywords: renal transplant recipients; omega-3 polyunsaturated fatty acids; cardiovascular mortality; all-cause mortality renal transplant recipients; omega-3 polyunsaturated fatty acids; cardiovascular mortality; all-cause mortality
Show Figures

Figure 1

MDPI and ACS Style

Gomes Neto, A.W.; Sotomayor, C.G.; Pranger, I.G.; Van den Berg, E.; Gans, R.O.B.; Soedamah-Muthu, S.S.; Navis, G.J.; Bakker, S.J.L. Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients. Nutrients 2017, 9, 363. https://doi.org/10.3390/nu9040363

AMA Style

Gomes Neto AW, Sotomayor CG, Pranger IG, Van den Berg E, Gans ROB, Soedamah-Muthu SS, Navis GJ, Bakker SJL. Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients. Nutrients. 2017; 9(4):363. https://doi.org/10.3390/nu9040363

Chicago/Turabian Style

Gomes Neto, António W., Camilo G. Sotomayor, Ilse G. Pranger, Else Van den Berg, Rijk O.B. Gans, Sabita S. Soedamah-Muthu, Gerjan J. Navis, and Stephan J.L. Bakker 2017. "Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients" Nutrients 9, no. 4: 363. https://doi.org/10.3390/nu9040363

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop